ReviewJCO oncology practice2024

Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Recent Advances and Strategies.

Francisco J Esteva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.